Skip to main content
. 2015 Jun 24;5:10.3402/iee.v5.27094. doi: 10.3402/iee.v5.27094

Table A.2.

Choice of drug conformity to guidelines

Conformity Non-conformity P
Doctors type General practitioner 54 (63.5%) 31 (36.5%) 0.765
Specialist practitioner 114 (61.6%) 71 (38.4%)
Gender of patients Male 90 (67.7%) 43 (32.3%) 0.069
Female 78 (56.9%) 59 (43.1%)
Age category 1–11 25 (47.2%) 28 (52.8%) 0.035
12–21 26 (72.2%) 10 (27.8%)
21–50 88 (62.0%) 54 (38.0%)
≥51 25 (73.5%) 9 (26.5%)
Residence Beyrouth 14 (58.3%) 10 (41.7%) 0.311
Mount Lebanon 50 (70.4%) 21 (29.6%)
Bekaa 1 (33.3%) 2 (66.7%)
North 32 (62.7%) 19 (37.3%)
South 70 (58.8%) 49 (41.2%)
Level of education of patients Elementary 24 (64.9%) 13 (35.1%) 0.555
Intermediate 18 (58.1%) 13 (41.9%)
Secondary 41 (63.1%) 24 (36.9%)
University 59 (67.8%) 28 (32.2%)
Is there any fever? Yes 98 (64.5%) 54 (35.5%) 0.316
No 66 (58.4%) 47 (41.6%)
How long did fever persist? 1 day 22 (53.7%) 19 (46.3%) 0.012
2 days 37 (64.9%) 20 (35.1%)
3 days 25 (75.8%) 8 (24.2%)
1 week 8 (88.9%) 1 (11.1%)
Laboratory culture Yes 34 (63%) 20 (37%) 0.931
No 134 (62.3%) 81 (37.7%)
HHS Vulnerability Disclosure